SCHEMBL24867162

SCHEMBL24867162

CC(C)C(=O)[C@H](N)CC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.39
FDPS P14324 1/20 0.35
GABRP O00591 2/20 0.34
GABRD O14764 2/20 0.34
GABRA1 P14867 2/20 0.34
GABRB1 P18505 2/20 0.34
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
GABRA5 P31644 2/20 0.34
GABRA3 P34903 2/20 0.34
GABRA2 P47869 2/20 0.34
GABRB2 P47870 2/20 0.34
GABRA4 P48169 2/20 0.34
GABRE P78334 2/20 0.34
GABRA6 Q16445 2/20 0.34
GABRG1 Q8N1C3 2/20 0.34
GABRG3 Q99928 2/20 0.34
GABRQ Q9UN88 2/20 0.34
SLC7A5 Q01650 1/20 0.34
SLC1A3 P43003 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24867161 1.00 DPP4 (0.39) DPP4FDPSGABRPGABRDGABRA1
SCHEMBL26552561 1.00 DPP4 (0.39) DPP4FDPSGABRPGABRDGABRA1
SCHEMBL16388300 0.82 FDPS (0.33) FDPSGABRPGABRDGABRA1GABRB1
SCHEMBL18821660 0.80 KDM4E (0.39) FDPSGABRPGABRDGABRA1GABRB1
SCHEMBL16018401 0.77
SCHEMBL8253827 0.75 DPP4 (0.41) DPP4SLC7A5GRIK1ALDH1A1MAPT
SCHEMBL15190002 0.75 DPP4 (0.41) DPP4SLC7A5GRIK1ALDH1A1MAPT
SCHEMBL197139 0.75 SLC7A5 (0.48) DPP4SLC7A5SLC1A3SLC1A2SLC1A1
SCHEMBL196695 0.75 SLC7A5 (0.48) DPP4SLC7A5SLC1A3SLC1A2SLC1A1
SCHEMBL15086350 0.75 DPP4 (0.41) DPP4SLC7A5GRIK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230008433-A1 Inhibitors of SARM1 DISARM THERAPEUTICS, INC. 2023-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230008433-A1 Inhibitors of SARM1 SARM1, SMN1; SMN2, SARNP DPP4 3330/4885FDPS 3904/4885GABRP 2175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.